The era of precision medicine is here and its promise to change clinical outcomes for patients with advanced cancers is just beginning
The Eileen Fund was created to advance the promise of better outcomes through iterative investigation to go after and defeat cancer at its core, aberrant molecular pathway activation leading to unregulated cell growth capable of taking a life.
Every hour trillions of our cells are following a metabolic pathway designed to sustain life and in doing so billions of cells replicate and create and maintain healthy tissues, the fabric of our lives. In this process, nature built-in protections for cells going through divisions to undergo programmed cell death (apoptosis) if unwanted changes occurred to that cell’s DNA or RNA, that could lead it to become a precancerous cell.
Unfortunately for some, the natural protective mechanisms that take out pre-cancerous cells are overcome, and a cancerous phenotype evolves and when established it rapidly replicates millions of times over eventually leading to a detectable mass (tumor) that if untreated takes the life of the individual.